GlassScriptPhysician profile
Devin N Sholty
NPI 1780345124
$4,425.18
in general payments reported to CMS, 2019-2025
39 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,885 · 2023: $1,227 · 2024: $178 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166 · Travel and Lodging: $262 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.93 |
| Travel and Lodging | $262.26 |
| Education | $111.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $719.59 | 2022-2024 | |
| Novo Nordisk INC | $459.74 | 2022 | |
| Medtronic, INC. | $379.69 | 2023 | Interstim |
| Amgen INC. | $347.68 | 2022-2025 | Evenity, Prolia |
| Glaxosmithkline, LLC. | $231.70 | 2022-2023 | Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $230.27 | 2022 | |
| Astellas Pharma US INC | $228.00 | 2023-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $210.83 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $163.23 | 2022-2023 | Breztri, Farxiga |
| Corium, LLC | $161.39 | 2022-2023 | Azstarys |
| Protega Pharmaceutials INC | $140.54 | 2022-2023 | Roxybond |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.87 | 2022 | |
| Scilex Pharmaceuticals INC. | $110.32 | 2022-2023 | Ztlido |
| Merck Sharp & Dohme LLC | $91.84 | 2022 | |
| Lilly USA, LLC | $77.37 | 2022-2023 | Mounjaro |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Sholty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.